Sharon Shacham
Equibles does not estimate personal net worth.
About Sharon Shacham
The proxy statement of Karyopharm Therapeutics Inc. reports total compensation of $6,037,789 for Sharon Shacham in fiscal 2022, including a base salary of $211,934. Disclosed compensation is on record for 5 fiscal years.
Affiliation history
-
Karyopharm Therapeutics Inc. (KPTIQ)
Proxy statement
Start not stated–2023-04-11
Last confirmed by a filing; no departure on record
-
Karyopharm Therapeutics Inc. (KPTIQ)
Proxy statement
Start not stated–2021-05-03
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Karyopharm Therapeutics Inc. (KPTIQ) | Former Chief Scientific Officer | $211,934 | $6,037,789 |
| 2021 | Karyopharm Therapeutics Inc. (KPTIQ) | Former Chief Scientific Officer | $499,905 | $3,106,591 |
| 2020 | Karyopharm Therapeutics Inc. (KPTIQ) | Former Chief Scientific Officer | $483,624 | $3,670,884 |
| 2019 | Karyopharm Therapeutics Inc. (KPTIQ) | Ph.D., M.B.A. Chief Scientific Officer and Former President | $468,500 | $3,020,459 |
| 2018 | Karyopharm Therapeutics Inc. (KPTIQ) | Ph.D., M.B.A. President and Chief Scientific Officer | $450,000 | $2,089,383 |
Recent activity
No call appearances or filed executive changes recorded yet.